


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+11.78%
-6.36%
+3.34%
+6.85%
ALEC
Alector
$1.89
ALEC Price Performance
$1.6 (+18.13%)
$1.25 (+51.20%)
$2.8 (-32.50%)
$1.76 (+7.39%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
Analysts perspectives on the stock desirability, trend direction and growth potential
ALEC has Low risk level
Risks Indicators

Price under $5

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Oct 23, 2025
Reiterate
Buy
HC Wainwright & Co.
Sep 24, 2025
Reiterate
Buy
H.C. Wainwright
ALEC
Alector
1.89
-1.05%
SLE
Super League Enterprise
5.40
-12.76%
NIO
NIO
4.70
-1.47%
CVX
Chevron
176.90
+3.34%
CRSP
CRISPR Therapeutics
49.96
-6.35%
What is ALEC current stock price?
What are ALEC stock strengths?
What is ALEC Risk Level?
What is ALEC market cap and volume?
What is ALEC current Stock IQ?
Should I buy ALEC stock right now?
Is ALEC a Strong Buy right now?
What does a 'Strong Buy' rating mean for ALEC?
What does a 'Strong Sell' rating mean for ALEC?
What factors influence ALEC's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+11.78%
-6.36%
+3.34%
+6.85%
ALEC
Alector
Current Price
$1.89
Recently Viewed
ALEC
Alector
1.89
-1.05%
SLE
Super League Enterprise
5.40
-12.76%
NIO
NIO
4.70
-1.47%
CVX
Chevron
176.90
+3.34%
CRSP
CRISPR Therapeutics
49.96
-6.35%

ALEC Price Performance
$1.6 (+18.13%)
$1.25 (+51.20%)
$2.8 (-32.50%)
$1.76 (+7.39%)
ALEC Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
Analysts perspectives on the stock desirability, trend direction and growth potential
ALEC has Low risk level
Risks Indicators

Price under $5

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Oct 23, 2025
Reiterate
Buy
HC Wainwright & Co.
Sep 24, 2025
Reiterate
Buy
H.C. Wainwright
ALEC Stock IQ
Stock Insights
Not Enough Information
ALEC Latest Analysis
INVESTOR ALERT: Levi &. Korsinsky is Investigating Alec Stock After its Phase 3 INFRONT-3 Clinical Trial Misses Co-Primary Endpoint. NEW YORK Jan. 29 2026 /PRNewswire/ -- Levi & Korsinsky LLP is investigating Alector Inc. (NASDAQ: ALEC) following the Companys announcement of topline results from its Phase 3 INFRONT-3 trial evaluating latozinemab in individuals with frontotemporal dementia due to a gene mutation...
Thu Jan 29, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ALEC Stock trends
ALEC Stock performance
ALEC Stock analysis
ALEC investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.